Insulin Resistance Syndrome could be key to preventing cardiovascular disease, cancer, diabetes and Alzheimer's

Aug 3 2007

New and important evidence shows that Insulin Resistance Syndrome can lead to elevated risk for cardiovascular disease, breathing and sleep disorders, liver disease, Polycystic Ovarian Syndrome, type 2 diabetes, certain cancers, Alzheimer's Disease and more.

This evidence will be presented at the 5th Annual World Congress on the Insulin Resistance Syndrome (WCIRS) in Boston, October 11-13, 2007. The Congress kicks-off with a symposium on Insulin Resistance and the Liver on Wednesday, October 10.

“Insulin Resistance Syndrome, an epidemic condition parallel to the obesity epidemic that dramatically increases the risk of developing type 2 diabetes, coronary heart disease, stroke, and various cancers, is estimated to affect at least one in three adults in America” said Dr. Gerald Reaven professor of medicine at Stanford School of Medicine.

The Insulin Resistance Syndrome, often referred to as the Metabolic Syndrome or Syndrome X, has been gaining worldwide attention since it was introduced in 1988 by Dr. Reaven. More than fifty of the world's foremost medical authorities will be on hand at the WCIRS to discuss the wide-reaching complications of Insulin Resistance. The Congress will examine the far-reaching effects of insulin resistance, its causes, prevention, and treatment. The Congress will also address the many manifestations of insulin resistance – heart disease, diabetes, fatty liver disease, sleep & breathing disorders, cancer, polycystic ovarian syndrome and certain brain disorders like Alzheimer's Disease.

“This metabolic disorder underlies some of the deadliest and most costly diseases in the U.S. An early intervention for prevention is critical” Said Dr. Yehuda Handelsman of the Metabolic Institute of America.

The World Congress of the IRS is jointly sponsored by PESI LLC and the Metabolic Endocrine Education Foundation, a non-profit foundation dedicated to educating physicians and the public on metabolic diseases and facilitating research in the field. The scientific organizing committee is the International Society for Insulin Resistance which is a group of global physician leaders- from diverse medical disciplines- dedicated to the understanding and educating of insulin resistance. The Congress is co-sponsored by The American Association of Clinical Endocrinologists (AACE), The American College of Endocrinology (ACE) and a host of participating organizations including: American Academy of Pediatrics, American Association for Study of Liver Disease (AASLD), American College of Nutrition, American Society of Clinical Nutrition (ASCN), American Society for Preventive Oncology (ASPO), Androgen Excess Society (AES), Canadian Association of Gastroenterology, International Academy of Cardiology, American Society of Endocrine Physician Assistants, International Association for the Study of Obesity, European Association for the Study of the Liver(EASL).

For more information and a complete list of participating organizations please visit http://www.insulinresistance.us.